Lowenstein Sandler advised Sonnet BioTherapeutics, while Sullivan & Worcester advised Chardan Capital Markets on the offering. Sonnet BioTherapeutics Holdings, Inc. (Nasdaq: SONN), a clinical-stage company developing...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Dragonfly Energy Holdings Corp. in the transaction. Dragonfly Energy Holdings Corp. (Nasdaq: DFLI), an industry leader in energy storage and manufacturer of lithium-ion...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Applied Digital Corporation in the transaction. Applied Digital Corporation (NASDAQ: APLD) announced the closing of a $125 million loan to fund the company’s...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler, Shibolet & Co. and Maples Group represented ZOOZ Power Ltd. in the transaction. Goldfarb Gross Seligman & Co., Ellenoff Grossman & Schole and Walkers...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction. Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction. Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced the sale of $26.5 million worth of stock in a...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics, Inc. (Nasdaq: COYA), a clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory...
You must be a Standard 1 Year member to access this content.
Lowenstein represented Coffee Holding Co, Inc. in the transaction. The U.S.-based wholesale coffee roaster and dealer Coffee Holding Co, Inc. announced its definitive merger and share exchange...
You must be a Standard 1 Year member to access this content.
Lowenstein represented BTIG, LLC, Oppenheimer & Co. Inc., and B. Riley Securities, Inc. as sales agents in the offering. Celularity, Inc. executed an at-the-market offering of up...
You must be a Standard 1 Year member to access this content.
Lowenstein represented ZyVersa Therapeutics in the transaction, while Alston & Bird advised Larkspur Health Acquisition Corp. Manatt, Phelps & Phillips advised A.G.P./Alliance Global Partners. ZyVersa Therapeutics,...
You must be a Standard 1 Year member to access this content.
